APA

Dhokia B., Canney P. A., Pectasides D., Munro A. J., Moore M., Wilkinson P. M., Self C. & Epenetos A. A. (19870304). A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer. : British journal of cancer.

Chicago

Dhokia B, Canney P A, Pectasides D, Munro A J, Moore M, Wilkinson P M, Self C and Epenetos A A. 19870304. A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer. : British journal of cancer.

Harvard

Dhokia B., Canney P. A., Pectasides D., Munro A. J., Moore M., Wilkinson P. M., Self C. and Epenetos A. A. (19870304). A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer. : British journal of cancer.

MLA

Dhokia B, Canney P A, Pectasides D, Munro A J, Moore M, Wilkinson P M, Self C and Epenetos A A. A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer. : British journal of cancer. 19870304.